Large Tuberculous Mass Lesions Involving the Brain: Outcomes and Management
Authors:
Open Access
- 4 June 2025
- journal article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 112 (6) , 1264-1266
Abstract
: The optimal management of large tuberculous mass lesions (LTML) involving the central nervous system remains unclear. We conducted a single-center, retrospective, observational study that assessed the outcomes of patients with LTML from January 2010 to February 2023. An LTML was defined as a tuberculoma or tubercular abscess exceeding or equal to 3 cm. The primary outcome was independence in activities of daily living, as assessed by the modified Rankin Scale (mRS) at a follow-up of 6 months. Forty-six patients were identified during the study period. Their mean age was 27.6 ± 12 years, the median duration of antituberculous therapy (ATT) was 18 months, and the median duration of follow-up was 20 months (interquartile range 15.7–40). The favorable outcomes were 76.9% (10/13) for ATT alone, 62.5% (10/16) for ATT with steroids, 87.5% (7/8) for ATT with surgery, and 66.9% (6/9) for ATT, steroids, and surgery. The median mRS at baseline in the study was 2 (1–3), and at the 6 month follow-up, it was 1 (0–2). Adding steroids or surgical intervention to ATT did not significantly improve primary outcomes (P = 0.637). Further large-scale studies are necessary to confirm these preliminary observations.Keywords
This publication has 11 references indexed in Scilit:
- Worsening CSF parameters after the start of anti-tuberculosis treatment predicts intracerebral tuberculoma developmentInternational Journal of Infectious Diseases, 2020
- Management of intracranial tuberculous mass lesions: how long should we treat for?Wellcome Open Research, 2020
- Presentation and outcome of patients with intracranial tuberculoma in a high HIV prevalence settingThe International Journal of Tuberculosis and Lung Disease, 2020
- Intensified adjunctive corticosteroid therapy for CNS tuberculomasInfection, 2020
- Surgery for brain tuberculosis: a reviewActa Neurochirurgica, 2015
- British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and childrenJournal of Infection, 2009
- Prognostic indicators in patients with intracranial tuberculoma: a review of 102 cases.2004
- A controlled clinical trial of short-course chemotherapy for tuberculoma of the brainTubercle and Lung Disease, 1995
- Intracranial tuberculoma: Conservative managementThe American Journal of Medicine, 1983
- Effect of prednisolone and rifampin on isoniazid metabolism in slow and rapid inactivators of isoniazidAntimicrobial Agents and Chemotherapy, 1980